Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06099509 · ClinicalTrials.gov registry record · NA
Self-Administered 2-Hour Oral Glucose Tolerance Test
A NA study, sponsored by Prisma Health-Upstate.
- Completed
- Registry status
- NA
- Development phase
- 200
- Enrollment target
NCT06099509 is a NA study that has completed, run by Prisma Health-Upstate. The registered enrollment target is 200 participants.
The verdict
NCT06099509, a NA study, has completed, sponsored by Prisma Health-Upstate.
- COMPLETED
- Registry status
- NA
- Development phase
- 200 participants
- Enrollment target
Study Summary
The goal of this randomized controlled trial is to evaluate whether self-administered postpartum diabetes screening tests in patients with gestational diabetes improves screening completion rates. The primary question it aims to answer is: 1\. Does a self-administered 75-gram oral glucose tolerance test with virtual follow-up visit increase the rate of postpartum diabetes screening within 12 weeks of delivery?
Interventions
- OTHER Self-administered oral glucose tolerance test
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2023-11-02 |
| Est. Completion | 2025-05-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06099509
The ClinicalTrials.gov registry entry for NCT06099509 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Prisma Health-Upstate, which has 67 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Self-administered oral glucose tolerance test is the first listed.
NCT06099509 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06099509 about?
NCT06099509 is a clinical study titled "Self-Administered 2-Hour Oral Glucose Tolerance Test". The goal of this randomized controlled trial is to evaluate whether self-administered postpartum diabetes screening tests in patients with gestational diabetes improves screening completion rates. The primary question it aims to answer is: 1\. Does a self-administered 75-gram oral glucose tolerance...
What is the current status of trial NCT06099509?
This trial is currently completed. It is a NA study. The enrollment target is 200 participants. The study started on 2023-11-02. Estimated completion is 2025-05-01.
What interventions are being tested in trial NCT06099509?
The interventions under investigation include: Self-administered oral glucose tolerance test (OTHER).
Who is sponsoring clinical trial NCT06099509?
This trial is sponsored by Prisma Health-Upstate, which has 67 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.